Treace Medical Concepts
TMCI
107 hedge funds and large institutions have $621M invested in Treace Medical Concepts in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 26 reducing their positions, and 8 closing their positions.
1,923% more call options, than puts
Call options by funds: $13M | Put options by funds: $641K
200% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 8
62% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 26
18% more funds holding
Funds holding: 91 → 107 (+16)
8% more capital invested
Capital invested by funds: $576M → $621M (+$45.1M)
4.24% more ownership
Funds ownership: 47.1% → 51.34% (+4.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$8.13M |
| 2 |
Allspring Global Investments
Charlotte,
North Carolina
|
+$8.11M |
| 3 |
PA
Perceptive Advisors
New York
|
+$7.93M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.68M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$4.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$2.79M |
| 2 |
Calamos Advisors
Naperville,
Illinois
|
-$1.52M |
| 3 |
AR
Advisory Research
Chicago,
Illinois
|
-$1.51M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$1.47M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$1.4M |
TMCI Hedge Fund Activity: Q4 2022 in Review
107 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q4 2022, worth a combined $621M — up 7.8% from $576M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new TMCI positions and 8 closed out — a net gain of 16 holders — while 42 added to existing stakes and 26 trimmed.
The largest buyer was CIBC Private Wealth Group, adding an estimated $8.13M. The largest seller was Janus Henderson Group, cutting an estimated $2.79M.
- 107 institutional investors held Treace Medical Concepts (TMCI) as of Q4 2022, up from 91 in Q3 2022.
- Funds reported $621M of Treace Medical Concepts stock for Q4 2022, up 7.8% quarter-over-quarter.
- 24 funds opened new Treace Medical Concepts positions in Q4 2022 and 8 closed out, a net change of +16 holders.
- The largest Treace Medical Concepts buyer in Q4 2022 was CIBC Private Wealth Group, an estimated $8.13M added.
- The largest Treace Medical Concepts seller in Q4 2022 was Janus Henderson Group, an estimated $2.79M sold.
Based on aggregated 13F filings for Q4 2022.